SRRK
Scholar Rock Holding CorporationNASDAQHealthcare$50.01+1.34%ClosedMarket Cap: $5.75B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
22.81
P/S
0.00
EV/EBITDA
-14.60
DCF Value
$1.79
FCF Yield
-5.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-145.9%
ROA
-93.5%
ROIC
-108.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-91.9M | $-91.0M | $-0.74 | — |
| FY 2025 | $0.00 | -Infinity% | $-384.6M | $-377.9M | $-3.29 | — |
| Q3 2025 | $0.00 | -Infinity% | $-103.5M | $-102.2M | $-0.90 | — |
| Q2 2025 | $0.00 | -Infinity% | $-112.1M | $-110.0M | $-0.98 | — |
| Q1 2025 | $0.00 | -Infinity% | $-77.1M | $-74.7M | $-0.67 | — |
| Q4 2024 | $0.00 | -Infinity% | $-69.4M | $-66.5M | $-0.67 | — |
| FY 2024 | $0.00 | -Infinity% | $-252.1M | $-246.3M | $-2.47 | — |
| Q3 2024 | $0.00 | -Infinity% | $-64.8M | $-64.5M | $-0.66 | — |
| Q2 2024 | $0.00 | -Infinity% | $-59.5M | $-58.5M | $-0.60 | — |
| Q1 2024 | $0.00 | -Infinity% | $-58.4M | $-56.9M | $-0.59 | — |
| Q4 2023 | $0.00 | -Infinity% | $-48.0M | $-46.1M | $-0.61 | — |
| FY 2023 | $0.00 | -Infinity% | $-171.3M | $-165.8M | $-1.99 | — |